Filed: 7/29/2025ACC: 0000950123-25-006717
📋 What this filing means
SANOFI filed this quarterly 13F‑HR report disclosing 10 equity positions with a total reported market value of $175.74M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
10
Positions
$175.74M
Total AUM (reported)
26.44M
Total Shares
Allocation by class
COM$129.86M73.9%
COM NEW$43.35M24.7%
SHS$2.53M1.4%
Portfolio Concentration
Top 3$141.12M80.3%
4–10$34.62M19.7%
Top 3 weight
80.3%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 26.44M
Sole
Full voting authority
26.44M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole10
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings10
Rows:
MeiraGTx Holdings plc
SOLEShares12.20M
TypeSH
Market value$79.53M
45.25%
Sole
12.20M
Shared
0.00
None
0.00
Novavax
SOLEShares6.88M
TypeSH
Market value$43.35M
24.67%
Sole
6.88M
Shared
0.00
None
0.00
AnaptysBio
SOLEShares821.92K
TypeSH
Market value$18.25M
10.38%
Sole
821.92K
Shared
0.00
None
0.00
Inhibrx Biosciences, Inc.
SOLEShares1.16M
TypeSH
Market value$16.52M
9.40%
Sole
1.16M
Shared
0.00
None
0.00
Omada Health Inc.
SOLEShares524.90K
TypeSH
Market value$9.61M
5.47%
Sole
524.90K
Shared
0.00
None
0.00
LAVA Therapeutics N.V.
SOLEShares1.92M
TypeSH
Market value$2.53M
1.44%
Sole
1.92M
Shared
0.00
None
0.00
Eledon
SOLEShares814.98K
TypeSH
Market value$2.21M
1.26%
Sole
814.98K
Shared
0.00
None
0.00
Inozyme, Inc
SOLEShares443.25K
TypeSH
Market value$1.77M
1.01%
Sole
443.25K
Shared
0.00
None
0.00
IGM Biosciences
SOLEShares1.44M
TypeSH
Market value$1.61M
0.92%
Sole
1.44M
Shared
0.00
None
0.00
Q32 Bio Inc.
SOLEShares244.08K
TypeSH
Market value$363.7K
0.21%
Sole
244.08K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MeiraGTx Holdings plcSOLE | COM | 12.20M | SH | $79.53M 45.25% | 12.20M | 0.00 | 0.00 |
NovavaxSOLE | COM NEW | 6.88M | SH | $43.35M 24.67% | 6.88M | 0.00 | 0.00 |
AnaptysBioSOLE | COM | 821.92K | SH | $18.25M 10.38% | 821.92K | 0.00 | 0.00 |
Inhibrx Biosciences, Inc.SOLE | COM | 1.16M | SH | $16.52M 9.40% | 1.16M | 0.00 | 0.00 |
Omada Health Inc.SOLE | COM | 524.90K | SH | $9.61M 5.47% | 524.90K | 0.00 | 0.00 |
LAVA Therapeutics N.V.SOLE | SHS | 1.92M | SH | $2.53M 1.44% | 1.92M | 0.00 | 0.00 |
EledonSOLE | COM | 814.98K | SH | $2.21M 1.26% | 814.98K | 0.00 | 0.00 |
Inozyme, IncSOLE | COM | 443.25K | SH | $1.77M 1.01% | 443.25K | 0.00 | 0.00 |
IGM BiosciencesSOLE | COM | 1.44M | SH | $1.61M 0.92% | 1.44M | 0.00 | 0.00 |
Q32 Bio Inc.SOLE | COM | 244.08K | SH | $363.7K 0.21% | 244.08K | 0.00 | 0.00 |